103 related articles for article (PubMed ID: 2192985)
1. [Control of the emesis induced by cisplatin in patients with head and neck neoplasms. Randomized study of metoclopramide alizapride and placebo].
Denaro A; Rossi M; Garozzo A; Matera M; Neri V
G Ital Oncol; 1990; 10(1-2):29-34. PubMed ID: 2192985
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplatin-induced emesis.
Saller R; Hellenbrecht D
Cancer Treat Rep; 1985 Nov; 69(11):1301-3. PubMed ID: 3912040
[TBL] [Abstract][Full Text] [Related]
3. [Phase I study of alizapride in cancer patients treated with cisplatin].
Nicaise C; Rozencweig M; Ortmans M; Frisque C; Bleiberg H
Sem Hop; 1983 Sep; 59(31):2161-5. PubMed ID: 6312589
[TBL] [Abstract][Full Text] [Related]
4. [Alizapride in a double-blind trial with metoclopramide in nausea and vomiting caused by radiotherapy].
Budach V; Krüger K
Fortschr Med; 1983 Oct; 101(39):1792-4. PubMed ID: 6642386
[TBL] [Abstract][Full Text] [Related]
5. [Alizapride in upper digestive endoscopy. A double-blind study vs metoclopramide and placebo].
Bongiorno A; Cataldo MG; Salvia A; D'Aiuto A; Ciranni C
Minerva Dietol Gastroenterol; 1989; 35(4):265-8. PubMed ID: 2695861
[TBL] [Abstract][Full Text] [Related]
6. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.
Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW
Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized double-blind crossover study comparing the antiemetic activity of alizapride and metoclopramide in patients receiving cisplatin chemotherapy.
Basurto C; Roila F; Del Favero A; Ballatori E; Minotti V; Tonato M
Cancer Invest; 1988; 6(5):475-9. PubMed ID: 3063335
[TBL] [Abstract][Full Text] [Related]
8. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
9. [Comparative double-blind study: alizapride-metoclopramide].
Oberling F
Ann Gastroenterol Hepatol (Paris); 1984; 20(1):59-61. PubMed ID: 6529162
[TBL] [Abstract][Full Text] [Related]
10. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
[TBL] [Abstract][Full Text] [Related]
11. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
12. Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Mae M; Fukuda M; Ohe Y; Sasaki S
Jpn J Clin Oncol; 1989 Mar; 19(1):40-4. PubMed ID: 2921817
[TBL] [Abstract][Full Text] [Related]
13. Anti-emetic effect of high-dose metoclopramide vs alizapride--a randomised crossover study.
Seng KT; Tiong CE; Hiang TC
Br J Clin Pharmacol; 1994 Sep; 38(3):282-4. PubMed ID: 7826833
[TBL] [Abstract][Full Text] [Related]
14. Control of nephrotoxicity by hydration-diuresis, and of emesis by alizapride, during cisplatin administration in patients with bladder cancer.
Neri B; Bartalucci S; Rizzo P; Nicita G; Ponchietti R
Riv Eur Sci Med Farmacol; 1988 Nov; 10(5):389-92. PubMed ID: 3079128
[No Abstract] [Full Text] [Related]
15. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
[TBL] [Abstract][Full Text] [Related]
16. [Antiemetic efficacy of betamethasone versus betamethasone combined with metoclopramide in cisplatin-treated cancer patients].
Kagami Y; Nishio M; Narimatsu N; Tomita M; Sakurai T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):807-10. PubMed ID: 2712578
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of antiemetic effect of clonazepam, metoclopramide, dexamethasone and diphenhydramine for prevention of cisplatin-induced vomiting].
Hatae M; Nakamura Y; Mitsuo M; Sakurai K; Asano H; Onishi Y; Hokanishi H
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1495-9. PubMed ID: 2389945
[TBL] [Abstract][Full Text] [Related]
18. [Comparative study of antiemetic properties of clebopride and metoclopramide in vomiting produced by cis-platinum (author's transl)].
Padrón F; Sanz J; Flórez J
Med Clin (Barc); 1981 Sep; 77(4):167-70. PubMed ID: 7031384
[No Abstract] [Full Text] [Related]
19. [Randomized control study of high-dose metoclopramide in the prevention of CDDP-induced emesis].
Sawamura N; Funaki Y; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Yoshioka S; Sakurai M; Eguchi K
Gan To Kagaku Ryoho; 1985 Apr; 12(4):943-6. PubMed ID: 3885865
[TBL] [Abstract][Full Text] [Related]
20. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
